Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (131-140 of 242) with videos related to

Pageof 25
Sort By:
The European Respiratory Journal|March 7, 2008
Sex differences in physiological progression of idiopathic pulmonary fibrosisM K Han, S Murray, C D Fell, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)Eric S White, Rachelle G Atrasz, Biao Hu, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2003
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumoniaVibha N Lama, Kevin R Flaherty, Galen B Toews, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2008
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosisCharlene D Fell, Lyrica Xiaohong Liu, Caroline Motika, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
The European Respiratory Journal|August 25, 2018
Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosisStephen M Humphries, Jeffrey J Swigris, Kevin K Brown, et al.
The European Respiratory Journal|March 12, 2016
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosisGanesh Raghu, Mary Beth Scholand, João de Andrade, et al.
Radiology|May 12, 2017
Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-upStephen M Humphries, Kunihiro Yagihashi, Jason Huckleberry, et al.
The Lancet. Respiratory Medicine|April 20, 2015
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsMichael T Durheim, Harold R Collard, Rhonda S Roberts, et al.
Respiratory Medicine|January 23, 2019
Lung function outcomes in the INPULSIS<sup>®</sup> trials of nintedanib in idiopathic pulmonary fibrosisKevin K Brown, Kevin R Flaherty, Vincent Cottin, et al.
Pageof 25

Showing results (131-140 of 242) with videos related to

Sort By:
Pageof 25
The European Respiratory Journal|March 7, 2008
Sex differences in physiological progression of idiopathic pulmonary fibrosisM K Han, S Murray, C D Fell, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)Eric S White, Rachelle G Atrasz, Biao Hu, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2003
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumoniaVibha N Lama, Kevin R Flaherty, Galen B Toews, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2008
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosisCharlene D Fell, Lyrica Xiaohong Liu, Caroline Motika, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
The European Respiratory Journal|August 25, 2018
Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosisStephen M Humphries, Jeffrey J Swigris, Kevin K Brown, et al.
The European Respiratory Journal|March 12, 2016
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosisGanesh Raghu, Mary Beth Scholand, João de Andrade, et al.
Radiology|May 12, 2017
Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-upStephen M Humphries, Kunihiro Yagihashi, Jason Huckleberry, et al.
The Lancet. Respiratory Medicine|April 20, 2015
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsMichael T Durheim, Harold R Collard, Rhonda S Roberts, et al.
Respiratory Medicine|January 23, 2019
Lung function outcomes in the INPULSIS<sup>®</sup> trials of nintedanib in idiopathic pulmonary fibrosisKevin K Brown, Kevin R Flaherty, Vincent Cottin, et al.
Pageof 25